Table II. Primary NSCLC cases that were positively immunostained with the selected mAbs.
| Tissue specimens testeda | Bsi0033 (Hptβ) | Bsi0077 (CFH) | Bsi0272 (C9) | Bsi0358 (ACT) | Bsi0392 (LRG1) |
|---|---|---|---|---|---|
| NSCLC | 64/80 (80%) | 69/80 (86%) | 59/80 (74%) | 74/80 (92%) | 0/81 |
| AC | 57/64 (89%) | 54/64 (84%) | 49/64 (77%) | 58/64 (91%) | 0/64 |
| SQC | 2/10 (20%) | 10/10 (100%) | 5/10 (50%) | 10/10 (100%) | 0/11 |
| LCC | 5/6 (83%) | 5/6 (83%) | 5/6 (83%) | 6/6 (100%) | 0/6 |
| SCLC | 3/18 (17%) | 2/19 (11%) | 1/16 (6%) | 3/17 (18%) | 0/15 |
| Normalb | 3/16 (19%) | 3/16 (19%) | 1/16 (6%) | 6/16 (37%) | 0/16 |
The number of positively stained tissue specimens (A) versus the total number of tested specimens (B) with each antibody is shown as ratio (A/B) and as a percentage.
a ADC, adenocarcinoma; LCC, large cell carcinoma; SCLC, small cell lung carcinoma. Normal included brain, spleen, heart, liver, skeletal muscle, smooth muscle, prostate, adrenal, kidney glomeruli, kidney tubule, thymus, lung alveoli and bronchi, and thyroid.
b The staining intensity in normal tissues noted as positive here, was only mild (2 in a intensity scale of 4 levels).